CLBS logo

Caladrius Biosciences (CLBS) Current Assets

CLBS Annual Current Assets

$96.18 M
+$60.85 M+172.23%

31 December 2021

CLBS Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLBS Quarterly Current Assets

$77.29 M
+$2.34 M+3.13%

01 September 2022

CLBS Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CLBS Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+172.2%-24.3%
3 y3 years+118.1%+155.6%
5 y5 years+56.7%+17.5%

CLBS Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall timeat high-32.2%

Caladrius Biosciences Current Assets History

DateAnnualQuarterly
Sept 2022
-
$77.29 M(+3.1%)
June 2022
-
$74.95 M(-17.4%)
Mar 2022
-
$90.70 M(-5.7%)
Dec 2021
$826.00 K(+23.1%)
$96.18 M(-5.8%)
Sept 2021
-
$102.11 M(-5.5%)
June 2021
-
$108.08 M(-5.2%)
Mar 2021
-
$114.03 M(+222.8%)
Dec 2020
$671.00 K(-43.2%)
$35.33 M(-14.4%)
Sept 2020
-
$41.26 M(+12.6%)
June 2020
-
$36.63 M(+72.7%)
Mar 2020
-
$21.21 M(-18.4%)
Dec 2019
$1.18 M(+149.2%)
$25.97 M(-14.1%)
Sept 2019
-
$30.24 M(-13.1%)
June 2019
-
$34.82 M(-12.2%)
Mar 2019
-
$39.65 M(-10.1%)
Dec 2018
$474.00 K(-76.0%)
$44.11 M(-6.7%)
Sept 2018
-
$47.25 M(-8.3%)
June 2018
-
$51.55 M(-5.5%)
Mar 2018
-
$54.53 M(-11.2%)
Dec 2017
$1.98 M(-93.1%)
$61.40 M(-6.7%)
Sept 2017
-
$65.77 M(-6.6%)
June 2017
-
$70.41 M(+221.0%)
Mar 2017
-
$21.93 M(-11.0%)
Dec 2016
$28.87 M(+3.3%)
$24.65 M(-17.7%)
Sept 2016
-
$29.96 M(+2.4%)
June 2016
-
$29.25 M(-17.9%)
Mar 2016
-
$35.62 M(+21.7%)
Dec 2015
$27.93 M(-69.0%)
$29.27 M(-23.9%)
Sept 2015
-
$38.48 M(-18.9%)
June 2015
-
$47.47 M(+63.6%)
Mar 2015
-
$29.02 M(-20.0%)
Dec 2014
$89.99 M(+130.8%)
$36.28 M(-12.4%)
Sept 2014
-
$41.41 M(+1.4%)
June 2014
-
$40.85 M(-12.2%)
Mar 2014
-
$46.56 M(-8.4%)
Dec 2013
$38.99 M(+3.4%)
$50.83 M(+149.9%)
Sept 2013
-
$20.34 M(+23.6%)
June 2013
-
$16.45 M(+29.8%)
Mar 2013
-
$12.68 M(-24.1%)
Dec 2012
$37.70 M(-67.7%)
$16.71 M(-65.1%)
Sept 2012
-
$47.89 M(-8.4%)
June 2012
-
$52.25 M(-1.4%)
Mar 2012
-
$52.98 M(+37.2%)
Dec 2011
$116.72 M(+21.4%)
$38.61 M(-14.4%)
Sept 2011
-
$45.10 M(+4.0%)
June 2011
-
$43.36 M(-14.0%)
Mar 2011
-
$50.44 M(+7.6%)
Dec 2010
$96.14 M
$46.88 M(+65.9%)
DateAnnualQuarterly
Sept 2010
-
$28.26 M(-27.1%)
June 2010
-
$38.76 M(-7.3%)
Mar 2010
-
$41.83 M(+31.5%)
Dec 2009
$79.28 M(+6027.0%)
$31.80 M(+397.7%)
Sept 2009
-
$6.39 M(-41.7%)
June 2009
-
$10.96 M(+1924.2%)
Mar 2009
-
$541.20 K(+2.0%)
Dec 2008
$1.29 M(-7.6%)
$530.40 K(-42.3%)
Sept 2008
-
$919.40 K(+38.0%)
June 2008
-
$666.30 K(-41.0%)
Mar 2008
-
$1.13 M(-52.4%)
Dec 2007
$1.40 M(+110.0%)
$2.38 M(-36.6%)
Sept 2007
-
$3.75 M(+1094.7%)
June 2007
-
$313.70 K(-74.9%)
Mar 2007
-
$1.25 M(+136.2%)
Dec 2006
$666.80 K(+392.5%)
$528.20 K(-62.3%)
Sept 2006
-
$1.40 M(+35.7%)
June 2006
-
$1.03 M(+367.8%)
Mar 2006
-
$220.50 K(-56.5%)
Dec 2005
$135.40 K(+169.2%)
$507.30 K(+1366.2%)
Sept 2005
-
$34.60 K(+71.3%)
June 2005
-
$20.20 K(-14.8%)
Mar 2005
-
$23.70 K(-51.7%)
Dec 2004
$50.30 K(-39.2%)
$49.10 K(-89.4%)
Sept 2004
-
$461.40 K(+4608.2%)
June 2004
-
$9800.00(-82.0%)
Mar 2004
-
$54.40 K(-76.2%)
Dec 2003
$82.70 K(-33.2%)
$229.00 K(-38.8%)
Sept 2003
-
$374.20 K(-65.5%)
June 2003
-
$1.08 M(+2.1%)
Mar 2003
-
$1.06 M(+0.2%)
Dec 2002
$123.80 K(-52.7%)
$1.06 M(-21.8%)
Sept 2002
-
$1.35 M(+3.8%)
June 2002
-
$1.30 M(-1.3%)
Mar 2002
-
$1.32 M(-16.0%)
Dec 2001
$261.90 K(-78.5%)
$1.57 M(-18.4%)
Sept 2001
-
$1.93 M(+3.3%)
June 2001
-
$1.87 M(-13.1%)
Mar 2001
-
$2.15 M(-15.3%)
Dec 2000
$1.22 M(+68.0%)
$2.54 M(-41.9%)
Sept 2000
-
$4.37 M(-14.8%)
June 2000
-
$5.12 M(-5.3%)
Mar 2000
-
$5.41 M
Dec 1999
$726.20 K(+918.5%)
-
Dec 1998
$71.30 K(>+9900.0%)
-
Mar 1998
$400.00(-42.9%)
-
Mar 1997
$700.00(-36.4%)
-
Mar 1996
$1100.00
-

FAQ

  • What is Caladrius Biosciences annual total current assets?
  • What is the all time high annual current assets for Caladrius Biosciences?
  • What is Caladrius Biosciences annual current assets year-on-year change?
  • What is Caladrius Biosciences quarterly total current assets?
  • What is the all time high quarterly current assets for Caladrius Biosciences?
  • What is Caladrius Biosciences quarterly current assets year-on-year change?

What is Caladrius Biosciences annual total current assets?

The current annual current assets of CLBS is $96.18 M

What is the all time high annual current assets for Caladrius Biosciences?

Caladrius Biosciences all-time high annual total current assets is $96.18 M

What is Caladrius Biosciences annual current assets year-on-year change?

Over the past year, CLBS annual total current assets has changed by +$60.85 M (+172.23%)

What is Caladrius Biosciences quarterly total current assets?

The current quarterly current assets of CLBS is $77.29 M

What is the all time high quarterly current assets for Caladrius Biosciences?

Caladrius Biosciences all-time high quarterly total current assets is $114.03 M

What is Caladrius Biosciences quarterly current assets year-on-year change?

Over the past year, CLBS quarterly total current assets has changed by -$24.82 M (-24.30%)